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Abstract. Metallopeptidase family M49 is characterized by five conserved sequence regions and the 
unique motif HEXXGH with two histidines - ligands of the active-site zinc ion. The crystal structure of 
the yeast ortholog represents a prototype for the whole family. 
To investigate the role of two invariant amino acid residues, a Glu461 of the zinc-binding motif, and 
a Tyr327, 21Å from the catalytic zinc center, mutational analysis of the yeast enzyme was performed. 
The substitution of Glu461 to glutamine decreased kcat for the substrate hydrolysis almost by 10 000-
fold. The replacement of Tyr327 by Phe or Ala reduced the catalytic efficiency (kcat/Km) by two orders 
of magnitude. The affinity for the heptapeptide valorphin was siginificantly lowered in all mutants, in-
dicating the contribution of both Glu461 and Tyr327 in substrate binding. Taken together, the effect of 
mutating Glu461 is consistent with this residue being essential in M49 peptidase catalysis. (doi: 
10.5562/cca2107) 
Keywords: enzyme catalysis, metallopeptidase, protein structure-function, site-directed mutagenesis, yeast 
Saccharomyces cerevisiae  
 
INTRODUCTION 
Hydrolysis of peptide bonds is essential for many biolo-
gical processes. Proteolytic enzymes (peptidases, prote-
ases) catalyze this reaction in vivo. Their physiological 
importance is reflected by the fact that ~2 % of the 
human genome encodes for peptidases.1 One of the  
four main peptidase classes are metallopeptidases, 
which are mostly zinc-dependent peptide-bond hydro-
lases.2 There are several classifications of 
metallopeptidases, with the one provided by the 
MEROPS database (http://merops.sanger.ac.uk) being 
perhaps the most accepted.3 This classification is based 
on the catalytic type and amino acid sequence similarity 
through which different families are recognized. 
Metallopeptidase family M49 (also known as pep-
tidase family M49, and dipeptidyl peptidase III family) 
is characterized by 5 conserved amino acid sequence 
regions and the unique hexapeptide linear motif 
HEXXGH which harbors two histidines - ligands of the 
active-site zinc ion.4 Members of this family participate 
in intracellular peptide metabolism. The breakthrough in 
the research of M49 peptidases was the elucidation of 
the crystal structure of the yeast orthologue in 2008, 
which revealed a two-domain protein with a new fold 
and represented a prototype for this family of proteases.5 
Since then, the investigation of the structure-function 
relationship of these metallopeptidases accelerated. 
Most of the work has been performed in the human 
ortholog by using site-directed mutagenesis, X-ray crys-
tallography and computational approaches, often in 
combination.6–8 
Much of the effort was directed towards defining 
the substrate binding site. Most recently, the first crystal 
structure of human M49 peptidase (dipeptidyl peptidase 
III, DPP III) in complex with the pentapeptide tynorphin 
was reported.8 This study discovered an exceptionally 
large domain motion upon ligand binding and con-
firmed some previous site-directed mutagenesis data 
which indicated the (functional) importance of con-
served amino acid residues from both protein domains 
for the enzyme activity.7,9 Meantime, there are still a 
number of unanswered questions regarding the catalytic 
mechanism of metallopeptidases of M49 family. One of 
them is the role of the evolutionary conserved glutamic 
acid residue which is part of the HEXXGH motif 
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(Glu451 in human and rat DPP III, Glu461 in yeast 
ortholog). Previous mutational analysis of the rat DPP 
III showed that Glu451 is essential for catalysis and not 
important for the zinc binding.10 Molecular dynamics 
simulations of human DPP III indicated the interactions 
of Glu451 with substrate and inhibitor.6 However, the 
experimental evidence for that is missing, since the only 
known crystal structure of the enzyme-ligand complex 
was elucidated for the E451A inactive mutant of the 
human ortholog.8 
There is also controversy regarding the function of 
the only conserved tyrosine residue in M49 peptidases 
(at the sequence position 318 in human, and at position 
327 in yeast peptidase). Mutational analysis of the hu-
man enzyme implied the importance of Tyr318 in transi-
tion state stabilization, but not in the small ligand bind-
ing (hydroxamate inihibitor Tyr-Phe-NHOH), while the 
X-ray crystallography pointed to the interaction of this 
residue with the pentapeptide ligand tynorphin.8,9  
In order to investigate the role of these two invariant 
amino acid residues of the M49 family peptidases, Glu461 
from the active-site motif HEXXGH, and Tyr327 from the 
conserved region 1 of the yeast ortholog,4,9 was replaced by 
Gln, and Phe as well as Ala, respectively, by site-directed 
mutagenesis, and the catalytic properties of generated 
purified enzyme variants were examined. 
 
EXPERIMENTAL 
Cloning and Site-directed Mutagenesis 
Yeast DPP III protein with a C-terminal hexa-histidine 
affinity tag was obtained by PCR amplification of the 
YOL057W gene using genomic DNA isolated from 
Saccharomyces cerevisiae (BY4741), and cloning into 
pET21a vector into the NdeI/XhoI restriction sites as 
reported previously by Jajčanin-Jozić et al.11 
Point mutations of the DPP III gene E461Q, 
Y327A and Y327F were carried out with QuickChange 
II XL Site-Directed Mutagenesis kit (Stratagene, USA) 
by using previously constructed vector (pET21a-
DPPIII6His) as a template, and primers listed in Table 1. 
All primers were custom synthesized by Invitrogen 
(USA) or by MWG Biotech AG (Ebersberg, Germany). 
DNA sequences of cloned constructs, as well confir-
mation of each mutant were obtained with automated 
sequence analyzer "ABI PRISM® 3100-Avant Genetic 
Analyzer" (Applied Biosystem, USA) and also by se-
quence analysis (MWG Biotech), using T7 forward and 
T7 reverse primers, as well as the internal DPP III pri-
mers: 5’-CATCAACCACTTTGTCACTGG-3’ and 5’-
CGATATAAAACTTGGCGGATGC-3’. 
 
Heterologous Expression and Purification of 
Recombinant Proteins 
Wild-type His6-tagged DPP III as well as the three sin-
gle variants E461Q, Y327A and Y327F were expressed 
in Escherichia coli, and purified employing affinity 
chromatography on nickel-nitrilotriacetic acid resin (Ni-
NTA Agarose, Qiagen) as described earlier.11 
Protein purity was confirmed by SDS-PAGE car-
ried out in T = 12.5 % polyacrylamide gel according  
to method of Laemmli12 and enzymatic activity was 
assayed using Arg2-2NA as substrate. All fractions  
of high purity were pooled and desalted on PD-10 col-
umns (GE Healthcare) equilibrated with 20 mmol dm–3 
Tris-HCl buffer, pH = 7.4. Purified protein preparations 
were stored in 15 mmol dm–3 Tris-HCl buffer, pH = 7.4 
containing 22 % glycerol at –10 C.  
Protein concentrations were determined using the 
method of Bradford, with bovine serum albumin as a 
standard13 and/or by measuring the absorbance at 280 
nm using the predicted extinction coefficients. 
 
Enzyme Activity Assay and Kinetic Analysis 
The enzymatic activity of yeast wild-type and mutant 
DPP III were determined spectrophotometrically by a 
standard assay at 37 C with Arg2-2NA as a substrate as 
described earlier.11 Kinetic parameters for hydrolysis of 
Arg2-2NA were determined fluorometrically at 25 C at 
pH = 8.0 in the presence of 100 µmol dm–3 solution of 
CoCl2 by initial rate measurements. The kinetic parame-
ters were calculated using a Hanes plot.11 
Affinities of wild-type and mutant DPP III for 
peptide valorphin (Ki values) were determined according 
to Chu and Orlowski.14 Hydrolysis of 15 µmol dm–3 
Arg2-2NA in 20 mmol dm–3 Tris-HCl buffer, pH = 8.0 
in the presence and absence of different concentrations 
of peptide was followed fluorimetrically at 25 C. Ki 
was calculated using the reaction rate at peptide concen-
tration which caused inhibition close to 50 %, by the 
equation Ki = I / (vo /vi – 1) × Km/(Km + S). 
Table 1. Primers used for site-directed mutagenesis of yeast M49 peptidase DNA 
Mutant Nucleotide sequence (5'–3') Primer I Nucleotide sequence (5'–3') Primer II 
Y327A cggttttatcgaaacagctagagaaccctcgggc gcccgagggttctctagctgtttcgataaaaccg 
Y327F cggttttatcgaaacatttagagaaccctcgggc gcccgagggttctctaaatgtttcgataaaaccg 
E461Q ccaagtaggcatccatcaattattaggacatggttcagg cctgaaccatgtcctaataattgatggatgcctacttgg 
Codons for the mutated residues are bolded. 
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Circular Dichroism Analysis 
The far-UV CD spectra were recorded on a JASCO  
J-815 spectropolarimeter at 25 C from 190–250 nm, 
using a quartz cuvette of 0.1 mm path length as de-
scribed earlier.11 
The protein concentration used for CD measure-
ments was 0.4 mg ml-1. 
 
RESULTS AND DISCUSSION 
Expression, Purification and Kinetic Characterization 
of Yeast M49 Peptidase and Its Mutants 
Recombinant yeast Saccharomyces cerevisiae metallo-
peptidase, wild-type and variants, was purifed by metal af-
finity chromatography as His-tagged proteins (Figure 1). 
Previously, we investigated the influence of His6-tag at 
the C-terminus of the yeast M49 peptidase on the wild-
type enzyme activity and did not find any significant 
change in kinetic parameters.11 
 
Replacement of Glutamate 461 to Glutamine 
The exchange of Glu461 to glutamine resulted in a dra-
matic reduction (9200-fold) in the kcat for the hydrolysis 
of the preferred synthetic substrate Arg-Arg-2-
naphthylamide (Arg2-2NA) and 2.8-fold increase in Km 
value (Table 2). 
The effect of the mutation on the protein structure 
was examined by circular dichroism (CD) analysis. The 
CD spectra of the wild-type and the E461Q variant were 
nearly identical, indicating that no change in secondary 
structure is caused by the Glu461 to glutamine substitu-
tion (Figure 2).  
Fukasawa et al. replaced Glu451, which is a structur-
al equivalent of yeast M49 peptidase Glu461, with an 
alanine or an aspartic acid residue in the rat DPP III (M49 
peptidase).10 These authors reported that the zinc content 
was unchanged in their variants (E451A and E451D), 
compared to wild-type, however, enzyme activity was not 
detectable, and hence kinetic parameters were not deter-
mined. Our present kinetic analysis of the yeast E461Q 
variant is thus the first quantitative study of this replace-
ment in the M49 family. 
Metallopeptidases represent the most diverse of 
the catalytic types of peptidases, with more than 60 
families (MEROPS). The majority of metallopeptidase 
families comprise enzymes containing the pentapeptide 
motif HEXXH at their active sites in which the two His 
are zinc ligands and the Glu has catalytic function (Ta-
ble 3). In the M49 family, the distance between the zinc-
ligating histidines is extended by one residue, and pep-
tidases of family M16 contain the HXXEH motif, an 
inversion of the more usual active-site HEXXH motif 
(Table 3). 
Figure 1. SDS-PAGE (12.5 % gel) analysis of the purification
progess of yeast M49 peptidase-His6 protein (E461Q mutant)
by affinity chromatography on Ni-NTA agarose column.
M – protein molecular mass standards; 1 – pellet; 2 - E.coli
cleared cell lysate containing recombinant M49 peptidase
protein; 3-4 – flow-through Ni-NTA column; 5-7 – Ni-NTA 
column wash steps with 20 mmol dm–3 imidazole; 8-9 – yeast 
M49 peptidase-His6 protein (E461Q mutant) eluted with 150
mmol dm-3 imidazole. Proteins were visualized by Coomassie
Blue staining. 
Table 2. Kinetic characterization (means ± S.E. for three 





Km / µmol dm–3 kcat / min–1 
Wild-type 15.18 ± 3.03   14.916 ± 3.36 
E461Q 42.13 ± 4.05 0.00162 ± 4.14×10–4 
Y327A 33.54 ± 2.25      0.072 ± 0.012 
Y327F 19.23 ± 0.11      0.108 ± 0.004 
The kinetic parameters Km and kcat were determined from the 
initial reaction rates at 25 C and pH = 8.0 with the Arg-Arg-
2NA, in the presence of 100 µmol dm–3 solution of CoCl2, 
using a Hanes plot. 
Figure 2. Circular dichroism spectra of wild-type yeast pepti-
dase M49 and E461Q mutant. 
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The importance of the glutamic acid residue in the 
active-site motif harboring two histidines has been in-
vestigated and confirmed by the site-directed mutagene-
sis in a number of zinc-dependent exo-and 
endopeptidases. In most cases, the effect replacing Glu 
in the active site were not quantified. In some cases, the 
same amount of recombinant wild-type enzyme and 
variant was used in the assay to compare their activi-
ties,15 while actually a much higher concentration of the 
variant is required to measure residual enzyme activity. 
Thompson et al. have exchanged the active-site gluta-
mate (Glu309) of the puromycin-sensitive amino-
peptidase, a member of family M1, to glutamine, ala-
nine and valine, and succeeded to characterize the vari-
ants kinetically, with amino acid β-naphthylamides as 
substrates.16 The E309Q variant showed 5700-fold to 
16,000-fold reduction in the kcat values, which is compa-
rable with the effect of replacing Glu461 to glutamine in 
yeast M49 peptidase (9200-fold reduction in the kcat for 
Arg-Arg-β-naphthylamide substrate). However, these 
authors did not observe significant change in Km val-
ues.16 
 
Replacement of Tyrosine 327 to Phenylalanine and 
Alanine  
The replacement of Tyr327 decreased the kcat of the yeast 
M49 peptidase for the hydrolysis of Arg2-2NA by two 
orders of magnitude (207-fold in Y327A, 138-fold in 
Y327F) relative to that of the wild-type enzyme (Table 
2). The Km value increased 2-fold in Y327A, and no 
significant change in Km was observed when Tyr327 was 
substituted by Phe. A very similar result was obtained 
previously for the human counterpart: Y318F variant 
showed a 100-fold lower kcat value compared to wild-
type, and no change in Km value.9 Interestingly, the 
Y318A variant of the human enzyme could not be ex-
pressed in E. coli, whereas the yeast Y327A variant was 
readily available. The reduction of catalytic efficiency 
(kcat /Km) was stronger when Tyr327 was replaced by Ala 
(460-fold versus 175-fold). The increase of Km, ob-
served with Y327A, indicated the importance of Tyr327 
for ligand binding.  
The function of a conserved tyrosine outside the 
zinc-binding motif was investigated in metallopeptidases 
of several other families. It was found to be essential for 
catalytic activity of aminopeptidase A and leukotriene A4 
hydrolase,17,18 both members of family M1, of neurolysin 
and thimet oligopeptidase (family M3).19 Furthermore, 
Tyr at position 157 is proposed to stabilize the transition 
state in thermolysin (family M4) as deduced from  
the crystallographic structures of enzyme-inhibitor com-
plexes.20 
 
Affinity for Valorphin 
Heptapeptide valorphin, H-Val-Val-Tyr-Pro-Trp-Thr-
Gln-OH, is a naturally occurring, endogenous opioide 
peptide of the hemorphin family. Hemorphins are de-
rived from the β-globin chain of hemoglobin.21 
Valorphin is among the peptides for which human 
metallopeptidase M49 (dipeptidyl peptidase III, DPP 
III) showed the highest affinity (Ki ~ 50 nmol dm–3).22 
At the same time, valorphin was a very poor substrate of 
the human enzyme. 
To investigate further the potential role of Tyr327 
and Glu461 in ligand binding, the affinity of the yeast 
wild-type and enzyme variants for this heptapeptide was 
determined by measuring the hydrolysis of Arg2-2NA 
and treating valorphin as alternate substrate inhibitor.14 
The determined Ki value of the yeast wild-type enzyme 
was 6.8-fold higher than that of its human counterpart.22 
The affinity of the E461Q mutant was decreased 25-
fold, and of the Y327A and Y327F, 17-fold and 15-fold, 
respectively compared to wild-type (Table 4), indicating 
the involvement of both Glu461 and Tyr327 in peptide 
binding to yeast DPP III. 
In contrast to Glu461, which is 3.9 Å apart from the 
catalytic zinc ion, Tyr327 is not situated in the vicinity of 
the catalytic site in ligand-free yeast peptidase M49 (the 
distance to Zn2+ is 21.4 Å) (Figure 3). Recently, the 
Table 4. Affinity of wild-type yeast M49 peptidase and its 
mutants for valorphin 
Enzyme form Ki / µmol dm–3 
Wild-type 0.34 ± 0.03 
E461Q 8.36 ± 1.52 
Y327A 5.85 ± 0.21 
Y327F 5.10 ± 0.27 
Ki values were determined with Arg-Arg-2NA as substrate at 
pH = 8.0, according to Chu and Orlowski.14 
Table 3. Alignment of the zinc binding motifs of different zinc 
metallopeptidases. APA: aminopeptidase A (EC 3.4.11.7), 
APN: aminopeptidase N (EC 3.4.11.2), PSA: puromycin-
sensitive aminopeptidase (EC 3.4.11.14), LTA4H: leukotriene 
A4 hydrolase (EC 3.3.2.6), TLN: thermolysin (EC 3.4.24.27), 
NEP: neprilysin (EC 3.4.24.11), DPP III: dipeptidyl peptidase 
III (3.4.14.4), IDE: insulysin, insulin-degrading enzyme (EC 
3.4.24.56). Bold black letters represent zinc-ligating histidines; 
glutamic acid residue involved in catalysis is underlined in red. 
Enzyme (family) Zinc binding motif 
APA (M1) VAHELVHQW 
APN (M1) IAHELAHQW 
PSA (M1) VGHELAHQW 
LTA4H (M1) IAHEISHSW 
TLN (M4) VAHELTHAV 
NEP (M13) IGHEITHGF 
DPP III (M49) GIHELLGHGS 
IDE (M16) LSHFCEHML 
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crystallographic structure of the human M49 peptidase-
ligand complex revealed that binding of the pentapep-
tide tynorphin (Val-Val-Tyr-Pro-Trp) induces a large 
domain motion in human enzyme.8 The conserved 
Tyr318, being 21.3 Å apart from the zinc-ligating His450 
residue in the free enzyme, thereby approaches to the 
distance of 6.5 Å, and contributes in ligand binding. 
Since the yeast and human peptidase M49 share the 
same protein fold, and are highly similar in the active-
site region, we suppose that the same domain motion 
occurs in the yeast enzyme, which rationalizes the func-
tional importance of Tyr327. 
The contribution of the glutamic acid residue of 
the active-site motif HEXXGH to the ligand binding of 
human and yeast M49 peptidase was indicated by our 
recent MD simulations.6,7 Our present study, revealing 
much weaker binding of valorphin to the mutant 
E461Q compared to the wild-type yeast enzyme, rep-
resents the first experimental evidence for the role of 
this Glu in substrate binding, since the only crystal 
structure of the enzyme-ligand complex was obtained 
with the E451A variant. 
Due to the dramatic decrease (9200-fold) observed 
in E461Q kcat, Glu461 is a residue essential for catalytic 
activity of yeast M49 peptidase. It is located only 3.9 Å 
apart of the active-site zinc ion and hydrogen-bonded to 
the water molecule that is the fourth ligand of zinc in 
the crystal structure of the yeast enzyme.5 Structurally 
equivalent to Glu461, glutamic acid residue is present in 
the active sites of two zinc endopeptidases, Glu143 in 
bacterial enzyme thermolysin, and Glu584 in mammalian 
peptidase neprilysin.5 For thermolysin, it has been shown 
that Glu143 acts as a general base in the deprotonation of 
the water molecule that attacks the scissile peptide 
bond.23 A similar activating role has been ascribed to 
Glu584 in neprilysin. Although structurally unrelated (Fig-
ure 4a), these three zinc peptidases have a very similar 
zinc coordination geometry through two histidines and 
one glutamic acid residue (His460, His465 and Glu517 in the 
yeast M49 peptidase) (Figure 4b). 
 
CONCLUSION 
The role of the two absolutely conserved amino acid 
residues in the M49 family of proteases was investigated 
by mutational analysis of the yeast Saccharomyces cere-
visiae ortholog. Glu461, situated in the upper protein  
domain, in the active-site motif HEXXGH, 3.9 Å from the 
catalytic zinc ion, and Tyr327, located 21.4 Å from the 
catalytic center, in the lower protein domain.  
The dramatic reduction of the substrate hydroylsis 
rate (9200-fold decreased kcat for Arg2-2NA) was ob-
served for the single mutant where Glu461 has been re-
placed by a glutamine suggesting that this glutamic acid 
residue is essential for enzyme catalysis. 
The substitution of Tyr327 by Ala or Phe decreased 
the kcat of the yeast M49 peptidase by 2 orders of magni-
tude. The reduction of catalytic efficiency (kcat/Km) was 
stronger when Tyr327 was replaced by Ala (460-fold vs. 
175-fold). 
Affinity of the wild-type and enzyme variants was 
determined for valorphin, a naturally occurring endoge-
nous opioid peptide (Val-Val-Tyr-Pro-Trp-Thr-Gln) by 
treating it as alternate substrate inhibitor. The affinity of 
the E461Q mutant for valorphin was decreased 25-fold, 
and of the Y327A and Y327F, 17-fold and 15-fold,  
respectively compared to the wild-type (Ki = 0.34 μmol 
dm–3), indicating the involvement of both Glu461 and 
Tyr327 in peptide binding to the yeast M49 peptidase. 
 
Figure 4. Crystal structures of the yeast M49 peptidase (PDB
code: 3csk), grey; thermolysin (PDB: 1 tmn), yellow,  and
neprilysin (PDB code: 1 dmt), pink (a). Superposition of the
zinc–coordinating residues of DPP III, thermolysin (PDB
code: 1 tmn) and neprilysin (PDB: 1 dmt) (b). 
Figure 3. Detail of the ligand-free yeast peptidase M49 crystal
structure showing the catalytic zinc ion (blue sphere),
conserved Glu461 and Tyr327. 
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